Koehler, Bruno Christian <br/><br/>
Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling.  [electronic resource] 

 -  BMC cancer  Nov 2015 
 - 919 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/s12885-015-1929-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Autophagy--drug effects<br/>Biphenyl Compounds--pharmacology<br/>Cell Culture Techniques<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Colorectal Neoplasms--drug therapy<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>HT29 Cells<br/>Humans<br/>Indoles<br/>Nitrophenols--pharmacology<br/>Piperazines--pharmacology<br/>Proto-Oncogene Proteins c-bcl-2--genetics<br/>Pyrroles--pharmacology<br/>Signal Transduction--drug effects<br/>Sulfonamides--pharmacology